This analysis was carried out to evaluate the potential of the CPPs with tumor-concentrating on Homes to deliver a cytotoxic payload to HCC cells. We explored utilizing a CXCR4-focusing on peptide, T22, fused with cytotoxic peptide PE24, to be a novel therapeutic technique for CXCR4+ HCC cells. T22 was selected given that the nanocarrier resulting